Professor Pietro Lampertico is the Director of the Gastroenterology and Hepatology Division, and Head of the Center for Liver Disease at the University of Milan. He has spoken internationally about liver disease, specifically the natural history of HBV and antiviral treatment of HBV and HDV, and has published several articles and book chapters. He is currently involved in national and international HBV and HDV clinical trials.

Dr Carey has a special interest in novel HBV infection biomarkers including their implementation into diagnostics and clinical management, HBV novel therapies leading to ‘functional cure’ – investigator and sub-investigator in phase 1–4 clinical trials. She is highly experienced in the management of viral infections during and post pregnancy including prevention of transmission from mother to child (UK guidelines), member of national HCV paediatric MDT ODN.

Dr Bell is a Consultant in Infectious Diseases and Acute Medicine working in Glasgow, UK and trained in Liverpool before taking up his Consultant post in 2010. Dr Bell looks after inpatients as well as running regular outpatient HIV and Hepatitis clinics. He leads the commercial clinical trial work in blood-borne viruses and has been a Principal Investigator for multiple Hep C, Hep B, and HIV treatment trials. Clinical interests include Hepatitis B, HIV as well as tropical infections.

Professor Stephen Ryder is lead clinician for the Hepatitis C NHS England Operational Delivery Network and Director of Research and Innovation at Nottingham University Hospitals. His major clinical and research interest is hepatitis C infection and large clinical trials in hepatology. Professor Ryder was recognised as one of the leading recruiters to commercial clinical trials in the “NIHR at 10” awards. Professor Ryder was the national lead for the Hepatology Clinical Research Network until 2015 and is now the Co-Director of the East Midlands CRN.